Plus Therapeutics, Inc. | CYTX - Interest Expense On Debt

Cytori Therapeutics reported $159K in Interest Expense on Debt for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Interest Expense On Debt Change
Baxter International BAX:US USD 125M 16M
Cerus CERS:US USD 1.7M 291K
Cytori Therapeutics CYTX:US USD 159K 14K
Infinity Pharmaceuticals INFI:US USD 45K 0
Northwest Biotherapeutics NWBO:US USD 1.51M 80K
Teva Pharmaceutical TEVA:IT USD 237M 7M